Skip to search formSkip to main contentSkip to account menu

anti-CD19 immunotoxin

Known as: Anti-CD19 Immunotoxins 
A monoclonal antibody linked to a toxic substance. It is being studied in the treatment of some types of B-cell cancer. Anti-CD19 immunotoxin is made… 
National Institutes of Health

Related topics

Related topics

1 relation

Narrower (1)

B43-PAP immunotoxin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Construction and expression of novel immunotoxin cpIL-4(13D)-PE38KDEL with increased activity
Interleukin-4 receptors (IL-4Rs) are expressed on a wide variety of human cancer cells, and therefore it may be a good option to… 
2005
2005
Construction and expression of novel immunotoxin cpIL-4(13D)-PE38KDEL with increased activity
Interleukin-4 receptors (IL-4Rs) are expressed on a wide variety of human cancer cells, and therefore it may be a good option to… 
1993
1993
Effects of the intermolecular toxin-monoclonal antibody linkage on the in vivo stability, immunogenicity and anti-leukemic activity of B43 (anti-CD19) pokeweed antiviral protein immunotoxin.
We have successfully constructed highly potent and selective anti-CD19 PAP immunotoxins using each of the three crosslinking… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)